FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

15364611000001100: NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1741601000001113 NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1741621000001118 NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Is a Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Has AMP NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Has specific active ingredient Etonogestrel true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Has dispensed dose form Vaginal delivery system true Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start